Table 2.
Summary statistics from health-facility based surveillance sites that received a single round of IRSa.
| MRCb (District) | Time period | Number of months included | Total outpatient visits, n | Suspected malaria cases, n (% of total) | Tested for malaria, n (% of suspected) | RDTc performed (versus microscopy), n (% of tested) | Confirmed malaria cases, n (% of tested) | Confirmed cases adjusted for testing rate, n | Mean monthly confirmed cases adjusted for testing rate, n |
|---|---|---|---|---|---|---|---|---|---|
| Aboke HCIV (Kole) | Baseline | 12 | 18,361 | 10,247 (55.8) | 8161 (79.6) | 7663 (93.9) | 6069 (74.4) | 7740 | 645 |
| Evaluation | 34 | 54,826 | 30,973 (56.5) | 30,674 (99.0) | 29,064 (94.8) | 22,097 (72.0) | 22,308 | 656 | |
| Aduku HCIV (Kwania) | Baseline | 12 | 25,439 | 14,912 (58.6) | 11,944 (80.1) | 4854 (40.6) | 6559 (54.9) | 8009 | 667 |
| Evaluation | 31 | 65,379 | 32,260 (49.3) | 31,337 (97.1) | 20,385 (65.1) | 15,201 (48.5) | 15,534 | 501 | |
| Anyeke HCIV (Oyam) | Baseline | 12 | 30,447 | 15,873 (52.1) | 11,324 (71.3) | 8628 (76.2) | 7947 (70.2) | 11,018 | 918 |
| Evaluation | 34 | 70,149 | 33,618 (47.9) | 32,522 (96.7) | 31,208 (96.0) | 21,799 (67.0) | 22,375 | 658 | |
| Awach HCIV (Gulu) | Baseline | 12 | 27,375 | 16,788 (61.3) | 15,124 (90.1) | 14,932 (98.7) | 11,293 (74.7) | 12,558 | 1047 |
| Evaluation | 30 | 69,375 | 36,760 (53.0) | 35,189 (95.7) | 34,070 (96.8) | 21,879 (62.2) | 22,851 | 762 | |
| Lalogi HCIV (Omoro) | Baseline | 12 | 39,517 | 24,235 (61.3) | 23,959 (98.9) | 23,951 (99.9) | 17,000 (71.0) | 17,202 | 1,434 |
| Evaluation | 31 | 72,449 | 41,846 (57.8) | 41,668 (99.6) | 40,804 (97.9) | 22,986 (55.2) | 23,060 | 744 | |
| Patongo HCIII (Agago) | Baseline | 12 | 21,745 | 13,482 (62.0) | 13,244 (98.2) | 12,938 (97.7) | 10,032 (75.7) | 10,142 | 845 |
| Evaluation | 34 | 54,486 | 34,482 (63.3) | 33,797 (98.0) | 32,176 (95.2) | 17,231 (51.0) | 17,440 | 513 | |
| Atiak HCIV (Amuru) | Baseline | 12 | 33,077 | 22,250 (67.3) | 19,224 (86.4) | 19,151 (99.6) | 16,450 (85.6) | 19,044 | 1,587 |
| Evaluation | 34 | 60,750 | 31,650 (52.1) | 30,754 (97.2) | 30,541 (99.3) | 19,766 (64.3) | 20,325 | 598 | |
| Padibe HCIV (Lamwo) | Baseline | 12 | 15,967 | 10,212 (64.0) | 10,096 (98.9) | 10,089 (99.9) | 8171 (80.9) | 10,089 | 841 |
| Evaluation | 28 | 50,117 | 26,883 (53.6) | 26,831 (99.8) | 25,956 (96.7) | 15,199 (56.6) | 15,224 | 544 | |
| Namokora HCIV (Kitgum) | Baseline | 12 | 20,291 | 16,969 (83.6) | 15,991 (94.2) | 14,918 (93.3) | 10,049 (62.8) | 10,722 | 894 |
| Evaluation | 31 | 56,765 | 40,185 (70.8) | 39,966 (99.5) | 38,468 (96.3) | 21,958 (54.9) | 22,063 | 712 |
aIndoor residual spraying.
bMalaria Reference Center.
cRapid diagnostic test.